Study guide

14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

Key Takeaways Explain This Topic AI

Trigeminal neuralgia causes paroxysmal electric-shock pain lasting seconds to two minutes and is treated first line with carbamazepine.

Bell's palsy is treated with oral prednisolone 50 to 60 mg daily for 10 days started within 72 hours, together with eye protection.

Bell's palsy is a lower motor neuron lesion affecting the forehead, which distinguishes it from a stroke.

Jaw claudication with scalp tenderness in an older patient suggests giant cell arteritis, which requires same-day high-dose corticosteroid to prevent irreversible blindness.

Long-term phenytoin therapy causes gingival enlargement that begins at the interdental papillae.

Last updated: September 2026

  • 3. Neurological Conditions: Epilepsy, Stroke, and Cranial Neuropathies
  • Cranial Neuropathies: Trigeminal Neuralgia, Bell's Palsy, and Giant Cell Arteritis Cranial Neuropathies
  • │
  • ┌─────────────────────────────────┼─────────────────────────────────┐
  • ▼ ▼ ▼
  • Trigeminal Neuralgia (CN V) Bell's Palsy (CN VII) Giant Cell Arteritis (GCA)
  • Unilateral, lancinating • Acute idiopathic LMN • Systemic vasculitis (>50 yrs)
  • paroxysms (V2 / V3) paralysis of whole face • Temporal headache, scalp
  • Triggered by light touch • Forehead paralysed tenderness
  • Normal neuro exam • Bell's phenomenon • Pathognomonic Jaw Claudication
  • Rx: Carbamazepine / MVD • Rx: Prednisolone (72 hrs) • Visual loss emergency (AION)
  • Corneal eye protection • Rx: High-dose Prednisolone

Feature Trigeminal Neuralgia (Tic Douloureux) Bell's Palsy (Idiopathic CN VII Palsy) Giant Cell Arteritis (Temporal Arteritis)

Anatomical Target Trigeminal Nerve (predominantly V2 & V3 ) Facial Nerve ( CN VII motor trunk) Medium/large cranial arteries (extracranial branches of ECA)

Patient Demographics Adults > 50 years > 50\text{ years} > 50 years ; females > males Any age (peak 20–40 years); equal sex Exclusively adults > 50 years > 50\text{ years} > 50 years (peak 70–80 years); females 3:1

Clinical Hallmarks Unilateral, excruciating, paroxysmal, electric-shock pain lasting seconds to 2 minutes Acute, unilateral, complete flaccid paralysis of all facial expression muscles, including forehead Severe temporal headache, scalp tenderness, jaw claudication during chewing

Provoking Factors Non-painful tactile stimuli to trigger zones (shaving, washing face, brushing teeth, light breeze) Acute idiopathic (often post-viral reactivation within fallopian canal) Provoked by continuous mastication (ischaemia of masseter/temporalis)

Neurological Exam Normal sensory and motor exam (no sensory deficit) Lower Motor Neurone (LMN) facial palsy ; loss of forehead wrinkling; eye closure failure Tender, swollen, nodular, pulseless superficial temporal artery

Medical Management Carbamazepine (100–1200 mg/day); oxcarbazepine; Microvascular Decompression Oral Prednisolone (50–60 mg/day for 10 days) within 72 hours; Eye protection IMMEDIATE Emergency high-dose Prednisolone (60 mg/day) to prevent permanent blindness

Trigeminal Neuralgia (Tic Douloureux)

Clinical Presentation: Paroxysms of sudden, unilateral, lancinating, electric-shock-like, stabbing pain strictly localized along the anatomical distribution of one or more divisions of the trigeminal nerve. The maxillary (V2) and mandibular (V3) divisions are involved in > 95 % >95\% > 95% of cases; the ophthalmic (V1) division is affected in < 5 % <5\% < 5% . Paroxysms last from a few seconds up to 2 minutes, followed by a refractory period during which further pain cannot be triggered.

Trigger Zones: Pain is provoked by trivial non-noxious tactile stimuli applied to cutaneous or mucosal trigger zones: washing the face, shaving, tooth brushing, eating, talking, or a cold breeze.

Diagnostic Distinction: In classical trigeminal neuralgia, the neurological sensory examination is completely normal . The presence of sensory loss (numbness, hypoaesthesia) indicates secondary trigeminal neuralgia (e.g., multiple sclerosis plaque or acoustic neuroma compressing the nerve root), requiring urgent brain MRI.

Differentiation from Odontogenic Pain: Unlike acute pulpitis, trigeminal neuralgia pain is non-continuous, is not provoked by thermal liquids, lacks periapical radiographic pathology, and follows discrete refractory cycles.

Management: Medical first-line therapy is Carbamazepine (100 mg twice daily, titrated up to 800–1200 mg daily; monitor full blood count for agranulocytosis and liver function). Surgical treatment: Microvascular Decompression (Jannetta procedure) via posterior fossa craniotomy to lift an aberrant arterial loop (most commonly the superior cerebellar artery ) compressing the trigeminal root entry zone at the pons.

Bell's Palsy

Bell's palsy is an acute, isolated, idiopathic Lower Motor Neurone (LMN) paralysis of the facial nerve (CN VII):

Clinical Signs: Rapid onset (peaks within 48 hours) of complete unilateral facial weakness:

Inability to raise the eyebrow or wrinkle the ipsilateral forehead (frontalis paralysis).

Inability to close the eye (orbicularis oculi paralysis); on attempted closure, the eyeball rolls upward and outward ( Bell's phenomenon ).

Drooping of the corner of the mouth, loss of the nasolabial fold, drooling of saliva, and flattening of the cheek (buccinator/orbicularis oris paralysis).

Hyperacusis (loss of stapedius muscle dampening) and loss of taste on the anterior two-thirds of the tongue (chorda tympani involvement).

UMN vs LMN Facial Nerve Palsy: In an Upper Motor Neurone lesion (e.g., Stroke) , the muscles of the upper face (forehead and eye closure) are spared because the dorsal portion of the facial motor nucleus in the pons receives bilateral corticonuclear innervation from both cerebral hemispheres. In an LMN lesion (Bell's palsy) , the final common motor pathway is severed, causing complete paralysis of the entire ipsilateral face, including the forehead .

UK Treatment Guidelines (NICE): Prescribe early high-dose oral corticosteroids: Prednisolone 50 to 60 mg daily for 10 days , initiated within 72 hours of symptom onset to reduce perineural oedema within the narrow osseous facial canal.

Corneal Protection: The primary complication is exposure keratitis, corneal ulceration, and permanent blindness due to the inability to blink or close the eye. The dentist/doctor must prescribe lubricating eye drops (artificial tears) by day, ophthalmic lubricating ointment at night, and instruct the patient to tape the eyelid closed or wear an eye patch while sleeping.

Giant Cell Arteritis (Temporal Arteritis)

Giant cell arteritis (GCA) is a systemic granulomatous panarteritis of medium- and large-sized arteries, preferentially targeting extracranial branches of the carotid arteries (superficial temporal, ophthalmic, and facial arteries):

Demographics: Occurs exclusively in patients over 50 years of age (median age 75); strong association with polymyalgia rheumatica (stiffness in shoulder and pelvic girdles).

Pathognomonic Triad:

Severe, new-onset unilateral temporal or occipital headache .

Scalp tenderness: Severe pain elicited by simple tactile contact, such as combing hair or resting the head on a pillow.

Jaw Claudication: Occurs in ~50% of patients. Severe fatigue, aching, or cramping pain in the masseter and temporalis muscles provoked specifically by mastication or continuous talking , which rapidly resolves upon resting the jaw. It is caused by reversible ischaemia in the branches of the maxillary artery supplying the masticatory apparatus.

The Catastrophic Hazard — Irreversible Blindness: Occlusion of the posterior ciliary arteries (branches of the ophthalmic artery) produces Anterior Ischaemic Optic Neuropathy (AION) , resulting in sudden, painless, permanent, irreversible blindness in the affected eye, which can spread to the contralateral eye within hours to days.

Investigations: Profoundly elevated inflammatory markers: Erythrocyte Sedimentation Rate (ESR) typically > 50 − 100 mm/hr > 50-100\text{ mm/hr} > 50 − 100 mm/hr and elevated C-Reactive Protein (CRP). Definitive diagnosis: Temporal Artery Biopsy (TAB) demonstrating transmural granulomatous infiltrate with multinucleated giant cells and fragmentation of the internal elastic lamina.

Emergency Dental Action: Giant cell arteritis is a medical ophthalmic emergency. If a dental patient presents with new temporal headache and jaw claudication, the dentist must immediately refer the patient to the emergency eye hospital or acute rheumatology service on the same day . High-dose systemic corticosteroids (oral Prednisolone 60 mg daily, or IV methylprednisolone) MUST be commenced immediately without waiting for biopsy results to preserve vision.

4. Clinical Traps, Diagnostic Pitfalls, and Worked Scenarios

Caution

Clinical Trap: Misdiagnosing Jaw Claudication as Temporomandibular Disorder (TMD): A 74-year-old female presents with bilateral pain in her masticatory muscles when chewing hard foods. The practitioner palpates tender masseter muscles and diagnoses myofascial pain dysfunction syndrome (TMD), fitting an acrylic occlusal splint. Two weeks later, the patient wakes up completely blind in her right eye. A detailed history would have revealed severe scalp tenderness when brushing her hair and a continuous right temporal headache. In any patient over 50 presenting with "jaw pain when chewing", giant cell arteritis must be actively excluded before diagnosing TMD.

Warning

Clinical Trap: Dental Extractions in Undetected Severe Liver Cirrhosis: Performing routine dental extractions on a patient with chronic alcoholic cirrhosis without a recent clotting screen and full blood count is hazardous. Severe deficiency of hepatic clotting factors (II, VII, IX, X) combined with hypersplenism-induced thrombocytopenia and impaired fibrinogen synthesis can result in intractable, life-threatening post-extraction haemorrhage. In suspected liver impairment, always obtain a current INR, APTT, and platelet count, and have local haemostatic agents readily available.

Worked Clinical SBA Scenario

Scenario: A 76-year-old female presents to your dental surgery complaining of severe, cramp-like pain in both cheeks and temples that develops after approximately two minutes of chewing solid food, forcing her to pause eating until the discomfort subsides. She also notes a persistent right-sided throbbing headache over the past three weeks and states that brushing her hair has become intensely painful. Palpation reveals a prominent, tender, non-pulsatile cord-like swelling over the right superficial temporal artery. There is no joint clicking or TMJ tenderness.

Question: What is the most likely diagnosis, what catastrophic complication is imminent, and what is the immediate management required of the dental practitioner?

Analysis and Clinical Governance: The clinical presentation of jaw claudication provoked by chewing solid food, combined with severe scalp tenderness when brushing hair and a unilateral temporal headache in a patient over 50 years of age, is classic for Giant Cell Arteritis (Temporal Arteritis) . The non-pulsatile, tender temporal artery reflects transmural granulomatous panarteritis. The most catastrophic risk is irreversible, permanent visual loss due to ischaemic optic neuropathy from posterior ciliary arterial occlusion. The dentist must recognize this as an acute medical emergency and arrange immediate same-day referral to an emergency ophthalmology department or acute medical team , ensuring high-dose oral corticosteroid therapy ( Prednisolone 60 mg daily ) is initiated immediately to safeguard the patient's vision.